NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression

Journal of Neurochemistry

Volumn 116, Issue 6, 2011, Pages 1160-1170

  Wang, Ruitao ^a,b   Zhang, Mingming ^a   Zhou, Weihui ^a   Ly, Philip T T ^a   Cai, Fang ^a   Song, Weihong ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

neurodegenerative disorders; NF B; transcription; ubiquitin; UCH L1

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR YY1; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN THIOLESTERASE; UBIQUITIN THIOLESTERASE L1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; EXON; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; BINDING SITES; CELL LINE; ENZYME INHIBITORS; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN THIOLESTERASE;

MUS;

EID: 79952427345     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07172.x     Document Type: Article

References (47)

1. Ardley H. C., Scott G. B., Rose S. A., Tan N. G., and, Robinson P. A., (2004) UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease. J. Neurochem. 90, 379-391. (Pubitemid 38938224)
2. Baldwin A. S. Jr, (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683. (Pubitemid 26130197)
3. Baud V., and, Karin M., (2009) Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat. Rev. Drug Discov. 8, 33-40.
4. Carmine Belin A., Westerlund M., Bergman O., Nissbrandt H., Lind C., Sydow O., and, Galter D., (2007) S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden. Parkinsonism Relat. Disord. 13, 295-298. (Pubitemid 47002329)
5. Chen C.-H., Zhou W., Liu S., Deng Y., Cai F., Tone M., Tone Y., Tong Y., and, Song W., (2011) Increased NF-kB signaling upregulates BACE1 expression and its therapeutic potential in Alzheimer's Disease. Int. J. Neuropsychopharmacol. (in press).
6. Choi J., Levey A. I., Weintraub S. T., Rees H. D., Gearing M., Chin L. S., and, Li L., (2004) Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J. Biol. Chem. 279, 13256-13264. (Pubitemid 38445905)
7. Christensen M. A., Zhou W., Qing H., Lehman A., Philipsen S., and, Song W., (2004) Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. Mol. Cell. Biol. 24, 865-874. (Pubitemid 38057936)
8. Das C., Hoang Q. Q., Kreinbring C. A., Luchansky S. J., Meray R. K., Ray S. S., Lansbury P. T., Ringe D., and, Petsko G. A., (2006) Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1. Proc. Natl Acad. Sci. USA 103, 4675-4680.
9. De Vrij F. M., Sluijs J. A., Gregori L., Fischer D. F., Hermens W. T., Goldgaber D., Verhaagen J., Van Leeuwen F. W., and, Hol E. M., (2001) Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death. FASEB J. 15, 2680-2688. (Pubitemid 33131094)
10. Diomedi-Camassei F., Rava L., Lerut E., Callea F., and, Van Damme B., (2005) Protein gene product 9.5 and ubiquitin are expressed in metabolically active epithelial cells of normal and pathologic human kidney. Nephrol. Dial. Transplant. 20, 2714-2719. (Pubitemid 41672270)
11. Doran J. F., Jackson P., Kynoch P. A., and, Thompson R. J., (1983) Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis. J. Neurochem. 40, 1542-1547. (Pubitemid 13106931)
12. Gapuzan M. E., Schmah O., Pollock A. D., Hoffmann A., and, Gilmore T. D., (2005) Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras. Oncogene 24, 6574-6583. (Pubitemid 41486640)
13. Ghosh S., May M. J., and, Kopp E. B., (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260. (Pubitemid 28183365)
14. Giasson B. I., and, Lee V. M., (2003) Are ubiquitination pathways central to Parkinson's disease? Cell 114, 1-8. (Pubitemid 36859837)
15. Gong B., Cao Z., Zheng P., et al. (2006) Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 126, 775-788. (Pubitemid 44233627)
16. Healy D. G., Abou-Sleiman P. M., Casas J. P., et al. (2006) UCHL-1 is not a Parkinson's disease susceptibility gene. Ann. Neurol. 59, 627-633.
17. Hershko A., and, Ciechanover A., (1998) The ubiquitin system. Annu. Rev. Biochem. 67, 425-479. (Pubitemid 28411135)
18. Hong S. M., Kelly D., Griffith M., Omura N., Li A., Li C. P., Hruban R. H., and, Goggins M., (2008) Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas. Mod. Pathol. 21, 1499-1507.
19. Hutter C. M., Samii A., Factor S. A., et al. (2008) Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease. Eur. J. Neurol. 15, 134-139.
20. Ichihara N., Wu J., Chui D. H., Yamazaki K., Wakabayashi T., and, Kikuchi T., (1995) Axonal degeneration promotes abnormal accumulation of amyloid beta-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse. Brain Res. 695, 173-178.
21. Kagara I., Enokida H., Kawakami K., et al. (2008) CpG hypermethylation of the UCHL1 gene promoter is associated with pathogenesis and poor prognosis in renal cell carcinoma. J. Urol. 180, 343-351.
22. Keller J. N., Hanni K. B., and, Markesbery W. R., (2000) Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436-439. (Pubitemid 30418211)
23. van Leeuwen F. W., de Kleijn D. P., van den Hurk H. H., et al. (1998) Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279, 242-247. (Pubitemid 28103884)
24. Leroy E., Boyer R., Auburger G., et al. (1998) The ubiquitin pathway in Parkinson's disease. Nature 395, 451-452.
25. Liu Y., Fallon L., Lashuel H. A., Liu Z., Lansbury P. T. Jr, (2002) The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 111, 209-218. (Pubitemid 35292441)
26. Lombardino A. J., Li X. C., Hertel M., and, Nottebohm F., (2005) Replaceable neurons and neurodegenerative disease share depressed UCHL1 levels. Proc. Natl Acad. Sci. USA 102, 8036-8041. (Pubitemid 40781058)
27. Lopez Salon M., Morelli L., Castano E. M., Soto E. F., and, Pasquini J. M., (2000) Defective ubiquitination of cerebral proteins in Alzheimer's disease. J. Neurosci. Res. 62, 302-310.
28. Mandelker D. L., Yamashita K., Tokumaru Y., et al. (2005) PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma. Cancer Res. 65, 4963-4968. (Pubitemid 40740837)
29. Mistry P., Deacon K., Mistry S., Blank J., and, Patel R., (2004) NF-kappaB promotes survival during mitotic cell cycle arrest. J. Biol. Chem. 279, 1482-1490. (Pubitemid 38082677)
30. Miyamoto S., and, Verma I. M., (1995) Rel/NF-kappa B/I kappa B story. Adv. Cancer Res. 66, 255-292.
31. Nishikawa K., Li H., Kawamura R., et al. (2003) Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. Biochem. Biophys. Res. Commun. 304, 176-183. (Pubitemid 36434213)
32. Osaka H., Wang Y. L., Takada K., et al. (2003) Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum. Mol. Genet. 12, 1945-1958. (Pubitemid 37038804)
33. Rogers J., (2008) The inflammatory response in Alzheimer's disease. J. Periodontol. 79, 1535-1543.
34. Setsuie R., and, Wada K., (2007) The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem. Int. 51, 105-111. (Pubitemid 47179898)
35. Setsuie R., Wang Y. L., Mochizuki H., et al. (2007) Dopaminergic neuronal loss in transgenic mice expressing the Parkinson's disease-associated UCH-L1 I93M mutant. Neurochem. Int. 50, 119-129. (Pubitemid 44879668)
36. Shishodia S., and, Aggarwal B. B., (2004) Nuclear factor-kappaB: a friend or a foe in cancer? Biochem. Pharmacol. 68, 1071-1080. (Pubitemid 39094272)
37. Siebenlist U., Franzoso G., and, Brown K., (1994) Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 10, 405-455.
38. Smith P. F., (2008) Inflammation in Parkinson's disease: an update. Curr. Opin. Investig. Drugs 9, 478-484. (Pubitemid 351677901)
39. Sun X., He G., Qing H., Zhou W., Dobie F., Cai F., Staufenbiel M., Huang L. E., and, Song W., (2006) Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl Acad. Sci. USA 103, 18727-18732. (Pubitemid 44913478)
40. Thompson R. J., Doran J. F., Jackson P., Dhillon A. P., and, Rode J., (1983) PGP 9.5-a new marker for vertebrate neurons and neuroendocrine cells. Brain Res. 278, 224-228. (Pubitemid 14219291)
41. Tokumaru Y., Yamashita K., Kim M. S., Park H. L., Osada M., Mori M., and, Sidransky D., (2008) The role of PGP9.5 as a tumor suppressor gene in human cancer. Int. J. Cancer 123, 753-759. (Pubitemid 352032399)
42. Tong Y., Zhou W., Fung V., Christensen M. A., Qing H., Sun X., and, Song W., (2005) Oxidative stress potentiates BACE1 gene expression and Abeta generation. J. Neural Transm. 112, 455-469. (Pubitemid 40868054)
43. Wang A. L., Yu A. C. H., Lau L. T., Lee C., Wu L. M., Zhu X. A., and, Tso M. O. M., (2005) Minocycline inhibits LPS-induced retinal microglia activation. Neurochem. Int. 47, 152-158. (Pubitemid 40848704)
44. Weissman A. M., (2001) Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2, 169-178. (Pubitemid 33675741)
45. Wilson P. O., Barber P. C., Hamid Q. A., Power B. F., Dhillon A. P., Rode J., Day I. N., Thompson R. J., and, Polak J. M., (1988) The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. Br. J. Exp. Pathol. 69, 91-104.
46. Xue S., and, Jia J., (2006) Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer's disease in a Chinese Han population. Brain Res. 1087, 28-32. (Pubitemid 43783159)
47. Zhang Z. J., Burgunder J. M., An X. K., et al. (2008) Lack of evidence for association of a UCH-L1 S18Y polymorphism with Parkinson's disease in a Han-Chinese population. Neurosci. Lett. 442, 200-202.